UNIC Athens has launched its new Evolve Lecture Series with an inaugural lecture by David Sinclair, Professor of Genetics at Harvard Medical School and one of the world’s foremost researchers on ...
Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
A Boston company treated its first patient with a therapy intended to allow aging optic nerve cells to behave as though they were young again. The experimental treatment by Life Biosciences will ...
The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
With a drug candidate in hand sooner than expected, NewLimit plans to push into a phase 1 fatty liver disease trial next year. (iStock / Getty Images Plus) Anti-aging startup NewLimit is back with a ...
AbstractNon apoptotic cell death programs particularly ferroptosis and cuproptosis are transforming how we understand cancer ...
With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a ...
Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results